Nyström Maija, Roine Jorma, Murtomaa Matti, Mohan Sankaran R, Santos Hélder A, Salonen Jarno
Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, Turku, Finland.
Laboratory of Industrial Physics, Department of Physics and Astronomy, University of Turku, Turku, Finland.
Eur J Pharm Biopharm. 2015 Jan;89:182-9. doi: 10.1016/j.ejpb.2014.11.027. Epub 2014 Dec 4.
The aim of the research was to verify that electrospraying of piroxicam yielded a new polymorphic form of this drug. In the experiments, piroxicam was dissolved in chloroform and the solution was atomised electrostatically. Subsequently, the charged droplets were neutralised and dried. The solid drug particles were collected and analysed by scanning electron microscopy, X-ray diffraction, differential scanning calorimetry, high performance liquid chromatography, and infrared and Raman spectroscopy. The X-ray diffractogram measured for the electrosprayed piroxicam particles did not match with any of the known piroxicam crystal structures (Cambridge Crystallographic Data Centre). The variable temperature X-ray diffraction showed that the structure recrystallised completely into piroxicam polymorphic formI during heating. No degradation products or solvate removal was detected by high performance liquid chromatography and thermal analysis. The infrared and Raman spectra of the electrosprayed piroxicam were compared to those of formI, and some notable differences in the peak positions, shapes and intensities were detected. The results indicate that electrospraying leads to piroxicam crystallisation in a currently unknown polymorphic form.
该研究的目的是验证吡罗昔康的电喷雾是否产生了这种药物的一种新的多晶型形式。在实验中,将吡罗昔康溶解于氯仿中,然后对该溶液进行静电雾化。随后,使带电液滴中和并干燥。收集固体药物颗粒,并通过扫描电子显微镜、X射线衍射、差示扫描量热法、高效液相色谱法以及红外和拉曼光谱法进行分析。对电喷雾的吡罗昔康颗粒测量得到的X射线衍射图与任何已知的吡罗昔康晶体结构(剑桥晶体学数据中心)均不匹配。可变温度X射线衍射表明,在加热过程中,该结构完全重结晶为吡罗昔康多晶型I。高效液相色谱法和热分析未检测到降解产物或溶剂化物去除。将电喷雾的吡罗昔康的红外光谱和拉曼光谱与多晶型I的光谱进行比较,检测到峰位置、形状和强度存在一些显著差异。结果表明,电喷雾导致吡罗昔康以目前未知的多晶型形式结晶。